The overexpression of PFKFB3 was observed in breast cancer [15], colon cancer [16], non-small cell lung cancer (NSCLC) [17], and hepatocellular carcinoma (HCC) [18]. Here, PFKFB3 is linked to hepatocellular carcinoma.